A Case of Switching from GnRH Agonist to Antagonist for Castration Resistant Prostate Cancer Control
GnRH antagonist and GnRH agonist are widely used as androgen deprivation therapy for metastatic prostate cancer. A previous report demonstrated that patients with PSA levels of >20 ng/mL using GnRH antagonists showed favorable outcomes in comparison to those using GnRH agonists. An 82-year old...
Сохранить в:
| Главные авторы: | , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Karger Publishers
2019-09-01
|
| Серии: | Case Reports in Oncology |
| Предметы: | |
| Online-ссылка: | https://www.karger.com/Article/FullText/502859 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|